This course will provide a thorough review of the principles underlying the practice of clinical EEG, including routine EEG in adults and children, long-term ambulatory and video-EEG monitoring in epilepsy, and EEG in critically ill patients. Faculty will present abnormal EEG in neonates and children. Topics will include normal maturation of EEG patterns from the neonatal period through adolescence. The session will build on information from Clinical EEG II by highlighting diffuse and focal abnormalities specific to pediatric EEG, and interictal and ictal epileptiform patterns seen in neonates and children. Multiple examples of focal abnormalities, diffuse abnormalities, and interictal and ictal EEG patterns will be presented. The session will end with interactive review of unknown EEG samples.
This program complements C188: Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs and C199: Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults, but covers independent topics.
Participants should be able to appropriately order EEG studies in the diagnostic evaluation of neurologic disorders in neonates and children, avoiding inappropriate use of EEG; identify normal and abnormal EEG patterns in pediatric patients; correctly interpret focal and diffuse EEG abnormalities in patients with epilepsy, focal brain disorders, and diffuse brain disorders; select the best EEG type in the diagnostic evaluation of epilepsy; identify interictal and ictal epileptiform patterns in neonates and children in outpatient, inpatient, and ICU settings; and correctly interpret focal and generalized epileptiform patterns to aid in seizure and epilepsy syndrome classification.
Medical Knowledge, Patient Care, Practice-Based Learning and Improvement
Program Speakers - Tentative
3:30 PM - 3:35 PM
Susan T. Herman MD, FAAN
3:35 PM - 4:20 PM
Normal and Abnormal EEG in Neonates and Children
Tammy Tsuchida MD, PhD
4:20 PM - 5:05 PM
Interictal and Ictal EEG in Neonates and Children
Tobias Loddenkemper MD
5:05 PM - 5:30 PM
Tobias Loddenkemper MD, Tammy Tsuchida MD, PhD
Susan T. Herman, MD, FAAN
Dr. Herman has received research support from Sage Therapeutics, UCB Pharma, Accorda Therapeutics, Electrical Geodesic, Inc, Epilepsy Therapy Development Program and Philips, Inc.
Tobias Loddenkemper, MD
Dr. Loddenkemper has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Zogenix, Engage, Upsher Smith, Eisai, Sunovion and Lundbeck. Dr. Loddenkemper has received personal compensation in an editorial capacity for Seizure.
Tammy Tsuchida, MD, PhD
Dr. Tsuchida has nothing to disclose.
Ready to register for the 2018 AAN Annual Meeting?